Cadrenal Therapeutics, Inc. Shareholders' Equity
Cadrenal Therapeutics, Inc. (CVKD) had Shareholders' Equity of $4.09 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $4.09M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $1.80M; Stockholders' Equity Attributable to Parent as first filed $1.80M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $2.74M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $2.73M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $4.09M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $1.80M 10-Q · filed 2026-08-13 | $1.80M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $2.74M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $2.73M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $4.30M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $6.11M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $7.44M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $3.41M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $3.99M 10-Q · filed 2025-11-10 | |
| 2024-03-31 | $6.19M 10-Q · filed 2025-08-11 | |
| 2023-12-31 | $7.69M 10-K · filed 2026-03-31 | |
| 2023-09-30 | $8.75M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $3.18M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $4.07M 10-Q · filed 2024-08-07 | |
| 2022-12-31 | -$5.55M 10-K · filed 2025-03-13 | |
| 2022-09-30 | -$1.18M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | -$670.84K 10-Q · filed 2023-11-09 | |
| 2022-03-31 | -$169.15K 10-Q · filed 2023-08-10 | -$169.15K 10-Q · filed 2023-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B |